Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial

Burt, R.K., Balabanov, R., Burman, J. et al. (20 more authors) (2019) Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial. Journal of the American Medical Association, 321 (2). pp. 165-174. ISSN 0098-7484

Abstract

Metadata

Authors/Creators:
  • Burt, R.K.
  • Balabanov, R.
  • Burman, J.
  • Sharrack, B.
  • Snowden, J.A. ORCID logo https://orcid.org/0000-0001-6819-3476
  • Oliveira, M.C.
  • Fagius, J.
  • Rose, J.
  • Nelson, F.
  • Barreira, A.A.
  • Carlson, K.
  • Han, X.
  • Moraes, D.
  • Morgan, A.
  • Quigley, K.
  • Yaung, K.
  • Buckley, R.
  • Alldredge, C.
  • Clendenan, A.
  • Calvario, M.A.
  • Henry, J.
  • Jovanovic, B.
  • Helenowski, I.B.
Copyright, Publisher and Additional Information: © 2019 American Medical Association.
Dates:
  • Published (online): 15 January 2019
  • Published: 15 January 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 24 Jan 2019 10:24
Last Modified: 24 Jan 2019 10:24
Published Version: https://doi.org/10.1001/jama.2018.18743
Status: Published
Publisher: American Medical Association
Refereed: Yes
Identification Number: https://doi.org/10.1001/jama.2018.18743
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics